HK1258611A1 - 腹水的治療 - Google Patents

腹水的治療

Info

Publication number
HK1258611A1
HK1258611A1 HK19100970.3A HK19100970A HK1258611A1 HK 1258611 A1 HK1258611 A1 HK 1258611A1 HK 19100970 A HK19100970 A HK 19100970A HK 1258611 A1 HK1258611 A1 HK 1258611A1
Authority
HK
Hong Kong
Prior art keywords
ascites
treatment
Prior art date
Application number
HK19100970.3A
Other languages
English (en)
Inventor
Paolo Angeli
Penelope Markham
Jonathan Adams
Original Assignee
Biovie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57609113&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1258611(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biovie Inc filed Critical Biovie Inc
Publication of HK1258611A1 publication Critical patent/HK1258611A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dermatology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
HK19100970.3A 2015-06-30 2019-01-18 腹水的治療 HK1258611A1 (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562186638P 2015-06-30 2015-06-30
US201562267510P 2015-12-15 2015-12-15
US201662321558P 2016-04-12 2016-04-12
PCT/US2016/040284 WO2017004317A1 (en) 2015-06-30 2016-06-30 Treatment of ascites

Publications (1)

Publication Number Publication Date
HK1258611A1 true HK1258611A1 (zh) 2019-11-15

Family

ID=57609113

Family Applications (1)

Application Number Title Priority Date Filing Date
HK19100970.3A HK1258611A1 (zh) 2015-06-30 2019-01-18 腹水的治療

Country Status (7)

Country Link
US (5) US9655945B2 (zh)
EP (2) EP4338795A2 (zh)
JP (5) JP2017014206A (zh)
CN (1) CN106999539A (zh)
ES (1) ES2971959T3 (zh)
HK (1) HK1258611A1 (zh)
WO (1) WO2017004317A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010032140A2 (en) 2008-09-17 2010-03-25 Chiasma Inc. Pharmaceutical compositions and related methods of delivery
CA2965325A1 (en) 2014-10-24 2016-04-28 Mallinckrodt Hospital Products IP Limited Method of treating patients with hepatorenal syndrome type 1
MA41462A (fr) 2015-02-03 2021-05-12 Chiasma Inc Méthode de traitement de maladies
JP2017014206A (ja) * 2015-06-30 2017-01-19 ナノアンティバイオティクス，インコーポレイテッド 腹水の治療
IL313083A (en) 2016-10-21 2024-07-01 Amryt Endo Inc Tralipressin compounds and methods of using them
CN112704727B (zh) * 2021-01-12 2023-05-16 重庆医科大学附属第二医院 特利加压素在制备动力性肠梗阻药物中的应用
CN113077888A (zh) * 2021-03-30 2021-07-06 福州宜星大数据产业投资有限公司 自动化meld评分方法、终端及存储介质
US20230241156A1 (en) * 2022-02-03 2023-08-03 Biovie Inc. Methods of treating disease with terlipressin

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1188443A1 (en) * 2000-09-15 2002-03-20 Ferring BV Improved protocol for paracentesis
US8222202B2 (en) * 2006-02-13 2012-07-17 Ferring B.V. Use of peptidic vasopressin receptor agonists
US9050286B2 (en) * 2007-08-14 2015-06-09 Ferring B.V. Use of peptidic vasopression receptor agonists
WO2009045309A2 (en) * 2007-09-28 2009-04-09 Ferring B.V. Use of v2 receptor antagonists in combination with vasopressinergic agonists
WO2009062174A1 (en) * 2007-11-08 2009-05-14 University Of Utah Research Foundation Use of angiogenesis antagonists in conditions of abnormal venous proliferation
US8815232B2 (en) * 2008-08-26 2014-08-26 Kyon Biotech Ag Compositions and methods for treating cancer
EP3282021A1 (en) * 2009-03-09 2018-02-14 Bioatla, LLC Mirac proteins
BRPI1012956A8 (pt) * 2009-06-08 2021-11-03 Ocera Therapeutics Inc Usos da l-ornitina e de pelo menos um de fenilacetato e fenilbutirato
BR112013000744A2 (pt) * 2010-07-14 2020-07-14 Cumberland Emerging Technologies, Inc uso de um antagonista de receptor de tromboxana a2 para prevenção ou tratamento de síndrome hepatorrenal,encefalopatia hepática,e doenças associadas
WO2013106072A1 (en) 2012-01-10 2013-07-18 Sorbent Therapeutics, Inc. Compositions comprising crosslinked cation-binding polymers and uses thereof
JO3109B1 (ar) * 2012-05-10 2017-09-20 Ferring Bv منبهات لمستقبلات v1a
CN102731625B (zh) * 2012-06-27 2014-10-15 深圳翰宇药业股份有限公司 一种纯化特利加压素的方法
CN105452857B (zh) * 2012-11-12 2019-06-28 科罗拉多州立大学董事会法人团体 评价慢性肝病的疾病严重性指标
CN105592855A (zh) * 2013-04-26 2016-05-18 拉卓拉药物公司 用于治疗肾衰竭的组合物和方法
CN104510840A (zh) * 2013-08-21 2015-04-15 乔治亚摄政研究学院有限公司 改性绿茶多酚和其用于治疗肝病的方法
JP2017014206A (ja) * 2015-06-30 2017-01-19 ナノアンティバイオティクス，インコーポレイテッド 腹水の治療

Also Published As

Publication number Publication date
US20230146264A1 (en) 2023-05-11
US20180000887A1 (en) 2018-01-04
EP4338795A2 (en) 2024-03-20
US20170000844A1 (en) 2017-01-05
JP2022136104A (ja) 2022-09-15
JP2018172440A (ja) 2018-11-08
US11364277B2 (en) 2022-06-21
JP2023160839A (ja) 2023-11-02
WO2017004317A1 (en) 2017-01-05
ES2971959T3 (es) 2024-06-10
CN106999539A (zh) 2017-08-01
US9655945B2 (en) 2017-05-23
US20240165193A1 (en) 2024-05-23
EP3347032B1 (en) 2023-11-29
JP2020172520A (ja) 2020-10-22
JP2017014206A (ja) 2017-01-19
EP3347032A4 (en) 2019-06-19
EP3347032A1 (en) 2018-07-18
US20190365848A1 (en) 2019-12-05

Similar Documents

Publication Publication Date Title
IL259110A (en) Treatment of osteoarthritis (osteoarthritis)
IL283258A (en) A preparation for the treatment of hypothyroidism
HK1248552A1 (zh) 使用川地匹坦的治療方法
PL3964213T3 (pl) Leczenie zaburzeń zachowania
ZA201706257B (en) Treatment of wood
HK1258611A1 (zh) 腹水的治療
GB201522243D0 (en) Treatment
GB201502137D0 (en) Treatment
ZA201706282B (en) Solid forms of menaquinols
GB201502404D0 (en) Water treatment
HK1249866A1 (zh) 用他塞利昔布進行治療的方法
GB201519450D0 (en) Novel treatment
IL255498A (en) Treatment of pruritus
GB201508841D0 (en) Treatment
GB201508385D0 (en) Metal treatment
HK1246679A1 (zh) 絲蟲病的治療
IL254336A0 (en) A new treatment method
GB201412010D0 (en) Treatment of hypertransaminasemia
GB201512139D0 (en) Methods of treatment
GB201503008D0 (en) Treatment
GB201514729D0 (en) Treatment of haemorrhoids
GB201510870D0 (en) Treatment of infarction
GB201522257D0 (en) Treatment of autism
GB201518349D0 (en) Treatment
GB201515739D0 (en) Treatment